EP1019711A4 - Methods and materials for optimization of electronic hybridization reactions - Google Patents
Methods and materials for optimization of electronic hybridization reactionsInfo
- Publication number
- EP1019711A4 EP1019711A4 EP97938378A EP97938378A EP1019711A4 EP 1019711 A4 EP1019711 A4 EP 1019711A4 EP 97938378 A EP97938378 A EP 97938378A EP 97938378 A EP97938378 A EP 97938378A EP 1019711 A4 EP1019711 A4 EP 1019711A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- buffer
- hybridization
- nucleic acids
- target nucleic
- factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000009396 hybridization Methods 0.000 title claims abstract description 42
- 238000000034 method Methods 0.000 title claims description 37
- 238000006243 chemical reaction Methods 0.000 title abstract description 12
- 239000000463 material Substances 0.000 title description 2
- 238000005457 optimization Methods 0.000 title description 2
- 239000000872 buffer Substances 0.000 claims abstract description 67
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims abstract description 30
- 235000018417 cysteine Nutrition 0.000 claims abstract description 26
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims abstract description 26
- 238000012360 testing method Methods 0.000 claims abstract description 11
- 238000004377 microelectronic Methods 0.000 claims abstract description 7
- 230000005684 electric field Effects 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 7
- 238000009825 accumulation Methods 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 150000007523 nucleic acids Chemical class 0.000 claims 21
- 102000039446 nucleic acids Human genes 0.000 claims 21
- 108020004707 nucleic acids Proteins 0.000 claims 21
- 229930014626 natural product Natural products 0.000 claims 2
- 230000002708 enhancing effect Effects 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 abstract description 17
- 235000001014 amino acid Nutrition 0.000 abstract description 16
- 239000003792 electrolyte Substances 0.000 abstract description 15
- 239000007853 buffer solution Substances 0.000 abstract description 6
- 108020004414 DNA Proteins 0.000 description 43
- 235000014304 histidine Nutrition 0.000 description 23
- 230000003139 buffering effect Effects 0.000 description 14
- 239000000243 solution Substances 0.000 description 10
- 241000894007 species Species 0.000 description 10
- 230000035945 sensitivity Effects 0.000 description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 150000001768 cations Chemical class 0.000 description 6
- 239000001488 sodium phosphate Substances 0.000 description 6
- 229910000162 sodium phosphate Inorganic materials 0.000 description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 6
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 6
- 239000012491 analyte Substances 0.000 description 5
- 239000008151 electrolyte solution Substances 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 239000006173 Good's buffer Substances 0.000 description 4
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 4
- 239000004472 Lysine Substances 0.000 description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- 150000001450 anions Chemical class 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 229940021013 electrolyte solution Drugs 0.000 description 4
- 235000018977 lysine Nutrition 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
- 108091036333 Rapid DNA Proteins 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- 229920001222 biopolymer Polymers 0.000 description 3
- 238000005251 capillar electrophoresis Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 229960003080 taurine Drugs 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 206010013457 Dissociation Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 description 1
- 239000007997 Tricine buffer Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 208000034953 Twin anemia-polycythemia sequence Diseases 0.000 description 1
- 238000002479 acid--base titration Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000007998 bicine buffer Substances 0.000 description 1
- 239000008364 bulk solution Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000004720 dielectrophoresis Methods 0.000 description 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
- URSLCTBXQMKCFE-UHFFFAOYSA-N dihydrogenborate Chemical compound OB(O)[O-] URSLCTBXQMKCFE-UHFFFAOYSA-N 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 208000018459 dissociative disease Diseases 0.000 description 1
- 238000010291 electrical method Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000012145 high-salt buffer Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 238000002218 isotachophoresis Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- -1 organic acid salts Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical group 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 230000005588 protonation Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 238000012358 sourcing Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L29/00—Semiconductor devices specially adapted for rectifying, amplifying, oscillating or switching and having potential barriers; Capacitors or resistors having potential barriers, e.g. a PN-junction depletion layer or carrier concentration layer; Details of semiconductor bodies or of electrodes thereof ; Multistep manufacturing processes therefor
- H01L29/66—Types of semiconductor device ; Multistep manufacturing processes therefor
- H01L29/66007—Multistep manufacturing processes
- H01L29/66075—Multistep manufacturing processes of devices having semiconductor bodies comprising group 14 or group 13/15 materials
- H01L29/66227—Multistep manufacturing processes of devices having semiconductor bodies comprising group 14 or group 13/15 materials the devices being controllable only by the electric current supplied or the electric potential applied, to an electrode which does not carry the current to be rectified, amplified or switched, e.g. three-terminal devices
- H01L29/66409—Unipolar field-effect transistors
- H01L29/66477—Unipolar field-effect transistors with an insulated gate, i.e. MISFET
- H01L29/6656—Unipolar field-effect transistors with an insulated gate, i.e. MISFET using multiple spacer layers, e.g. multiple sidewall spacers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6832—Enhancement of hybridisation reaction
Definitions
- This invention relates to buffers and electrolytes for use in electronic devices adapted for medical diagnostic, biological and other uses. More particularly, it relates to buffers and electrolytes for advantageous use with DNA hybridization analysis carried out on microelectronic medical diagnostic devices.
- APEX systems are able to perform a wide variety of functions which are advantageously used in molecular biology reactions, such as nucleic acid hybridizations, antibody/antigen reactions, clinical diagnostics, and biopolymer synthesis.
- APEX-type devices utilize buffers and electrolytes for their operation.
- a buffer has been defined as a chemical solution which is resistant to change in pH on the addition of acid or alkali. See., e.g., Dictionary of Biotechnology, Second Edition, James Coombs, Stockton Press. As stated there, "traditionally, buffers based on inorganic salts (phosphate, carbonate) and organic acid salts (acetate, citrate, succinate, glycine, maleate, barbiturates, etc.) were used in biological experiments.” It is the object of this invention to discover buffers and electrolytes which are advantageously used in molecular biology electronic devices which perform hybridizations, reactions, diagnostics or synthesis.
- the following inventions relate to our discoveries concerning the various parameters, electrolytes (buffers) , and other conditions which improve or optimize the speed of DNA transport, the efficiency of DNA hybridization reactions, and the overall hybridization specificity in our APEX microelectronic chips and devices.
- this invention relates to the discovery that low conductance zwitterionic buffer solutions, especially those containing the amino acid Histidine prepared at concentrations of 10-100 mM, preferably about 50 mM, and at or near the pi (isoelectric point -pH 7.47), provide optimal conditions for both rapid DNA transport and efficient hybridization reactions.
- Hybridization efficiencies of at least a factor of 10 relative to the next best known buffer, Cysteine are achieved.
- Test data demonstrate an approximately 50,000 fold increase in hybridization efficiency compared to Cysteine.
- Fig. 1 is a plan view of a checkerboard arrangement utilizing a histidine buffer.
- Genosensor impedance sensors
- Optical and Electrical Methods and Apparatus for Molecular Detection 093/22678
- dielectrophoresis devices see, e.g., Washizu 25 Journal of Electrostatics, 109-123, 1990
- AC electric fields An important distinction related to these devices is that when these AC fields are applied, there is essentially no net current flow in any of these systems, i.e, there is no electrophoretic propulsion for transport of the charged molecules.
- APEX type devices produce significant net direct current (DC) flow when a voltage is applied, which is recognized as "the signature of electrophoresis” .
- electrophore- sis the migration of ions or charged particles is produced by electrical forces along the direction of the electric field gradient, and the relationship of current and voltage are important to this technology.
- I is the electric current [A] .
- the resistance of the solution is the reciprocal of the conductance which can be measured by a conductomete .
- the conductance depends mainly on the ionic species of the buffer/electrolytes and their concentration; therefore these parameters are very important for electric field related molecular biology technology.
- the basic current/voltage relationships are essentially the same for the APEX technology as for any other electrophoretic system, although the electric fields produced are in truly microscopic environments.
- There are unique features of the APEX system regarding the various ways of sourcing the current and voltage, and how the current and voltage scenarios have been found to improve the performance of such systems . In particular, various DC pulsing procedures (linear and logarithmic gradients) appear to provide improved hybridization stringency.
- the ionic strength and conductance are equivalent, i.e., the conductance will usually be proportional to the ionic strength.
- buffering electrolytes phospr e, acetate, citrate, succinate, etc.
- the ionic strength and conductance will usually be equivalent, i.e., conductance is proportional to the ionic strength.
- an amino acid in its zwitterionic state ( " OOC-CH(R) -NH 3 *) will have a conductance value which will be approximately 1000 fold lower than when the " amino acid moiety" has a full net positive charge (HOOC-CH(R) -NH 2 * ⁇ > x" ) or a full negative charge (Y + ⁇ > " OOC-CH (R) -NH 2 ) .
- a formal negative or positive charge develops on the amino acid moiety as it moves away from its pi, and the conductivity and ionic strength will begin to correlate.
- the conductance will be much lower than is expected for that given ionic strength or concentration.
- electrophoresis texts refer to the Good Buffers and amino acid buffers as having "low conductances at high ionic strength or concentration" (see page 88 of Capillary Electrophoresis: Principles and Practice", R. Kuhn and S. Hoffstetter, Springer - Verlag, 1993) .
- a commonly used electrophoresis buffer “Tris-Borate” actually has a significantly lower conductivity than would be expected from its ionic strength or concentration. This may be due to the "tris cation” and “borate anion” forming a relatively stable zwitterionic complex in solution.
- the conductivity of a 100 mM Tris-Borate solution was determined to be 694 ⁇ S/cm, which is approximately 20 times lower than would be expected from its ionic strength, and is roughly equiva- lent to a 5 mM sodium phosphate or sodium chloride solution.
- Table 1 shows conductivity measurements of a number of transport buffers.
- Amino acid buffers do have buffer properties at their pi's. While a given amino acid may or may not have its "highest buffering capacity" at its pi, it will have some degree of buffering capacity. Buffer capacity decreases by a factor of 10 for every pH unit difference between the pi and the pKa; those amino acids with three ionizable groups (histidine, cysteine, lysine, glutamic acid, aspartic acid, etc.) generally have higher buffering capacities at their pi's than those amino acids with only two dissociations (glycine, alanine, leucine, etc.).
- Histidine has been proposed as a buffer for use in gel electrophoresis, see, e.g., U.S. Patent 4,936,963, but hybridization is not performed in such systems. Cysteine is in a more intermediate position, with regard to buffering capacity.
- the pi of cysteine is 5.02, the pKa for the carboxyl group is 1.71, the pKa for the sulfhydryl is 8.33, and the pKa for amino group is 10.78.
- An acid /base titration curve of 250 mM cysteine shows that cysteine has a better "buffering capacity" at ⁇ pH 5 than a 20 mM sodium phosphate. In the pH 4 to 6 range, the buffering capacity of cysteine is significantly better than 20 mM sodium phosphate, particularly at the higher pH.
- Fig. 1 shows a plan view of an APEX chip using histidine.
- the instant invention relates to our discoveries concerning the various parameters, electrolytes (buffers) , and other, conditions which improve or optimize the speed of DNA transport, the efficiency of DNA hybridization reactions, and the overall hybridization specificity in electric field molecular biology devices, especially APEX microelectronic chips and devices.
- this invention relates to our discovery that low conductance zwitterionic buffer solutions containing the amino acid Histidine prepared at concentrations of 10-100 mM, especially about 50 mM, at or near the pi (isoelectric point -7.47), provide optimal conditions for both rapid electrophoretic DNA transport and efficient hybridization reactions. This advantage of the Histidine buffer is particularly important for the APEX chip type devices .
- Table 2 shows the effect of various zwitterionic amino acid buffers [j ⁇ -Alanine, Taurine, Cysteine, Histidine, Lysine, and Sodium Phosphate (not a zwitterionic buffer) ] on the hybridizability of the transported target DNA to the specific capture DNA at the test site.
- transport the conductivity generally correlates with transport under the same field conditions.
- 3-Alanine, Taurine and Cysteine show excellent transport
- Histidine shows good transport
- Lysine and NaP0 4 show fair transport.
- the DNA hybridization sensitivity is reported for "normal DNA" which has negatively charged polyanionic phosphate backbone.
- Table 2 also reports the sensitivity for the streptavidin/biotin DNA probe capture affinity.
- Table 2 clearly shows the correlation of DNA transport (accumulation) with low conductivity (j ⁇ -Alanine, Taurine, Cysteine, Histidine) .
- the table shows good
- Histidine is the only one which provides both good transport and good DNA/DNA hybridization efficiency. It is believed that the low conductivity of the Histidine buffer system accounts for the rapid DNA transport (accumulation) . There are several possible explanations as to why the Histidine buffer produces relatively efficient DNA/DNA hybridization.
- One advantage may be the good buffering capacity of Histidine. With its pi at 7.47, Histidine will buffer well under both acidic or basic conditions (see A.L. Lehninger, Biochemistry, 2ed, Worth Publishers, New York, 1975, Fig. 4-9 on page 80) .
- the APEX chip produces acid at the positive electrode where the DNA is accumulated for hybridization, and Histidine may effectively buffer these conditions.
- DNA/DNA/Histidine may also form some type of stabilizing adduct from other electrochemical products being produced at the positive electrode (hydrogen peroxide, etc.) While the instant embodiment utilizes naturally occurring Histidine, this invention is fully applicable to other natural or synthetic compounds which have good buffering capacity, low conductivity (or zwitterionic characteristics) and have properties which allow DNA hybridization to be stabilized by charge stabilization or adduct formation.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Power Engineering (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Biophysics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Ceramic Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Computer Hardware Design (AREA)
- Electrochemistry (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
Abstract
The following inventions relate to discoveries concerning the various parameters, electrolytes (buffers), and other conditions which improve or optimize the speed of DNA transport, the efficiency of DNA hybridization reactions, and the overall hybridization specificity in microelectronic chips and devices. In particular, this invention relates to the discovery that low conductance zwitterionic buffer solutions, especially those containing the amino acid Histidine prepared at concentrations of ∩50 mM and at or near the pI (isoelectric point ∩pH 7.47), provide optimal conditions for both rapid electrophoretic DNA transport and efficient hybridization reactions. Hybridization efficiencies of at least a factor of 10 relative to the next best known buffer, Cysteine, are achieved. Test data demonstrate an approximately 50,000 fold increase in hybridization efficiency compared to Cysteine.
Description
DESCRIPTION
Methods And Materials For Optimization Of Electronic Hybridization Reactions
Field of the Invention
This invention relates to buffers and electrolytes for use in electronic devices adapted for medical diagnostic, biological and other uses. More particularly, it relates to buffers and electrolytes for advantageous use with DNA hybridization analysis carried out on microelectronic medical diagnostic devices.
Background of the Invention
Recently, there has been increasing interest in devices which combine microelectronics and molecular biology. One such system is disclosed in "ACTIVE PROGRAMMABLE ELECTRONIC DEVICES FOR MOLECULAR BIOLOGICAL ANALYSIS AND DIAGNOSTICS", Serial No. 08/146,504, filed November 1, 1993, now issued as United States Patent No. 5,605,662, incorporated herein by reference. The systems disclosed therein will be referred to as APEX systems. APEX systems are able to perform a wide variety of functions which are advantageously used in molecular biology reactions, such as nucleic acid hybridizations, antibody/antigen reactions, clinical diagnostics, and biopolymer synthesis.
APEX-type devices utilize buffers and electrolytes for their operation. A buffer has been defined as a chemical solution which is resistant to change in pH on the addition of acid or alkali. See., e.g., Dictionary of Biotechnology, Second Edition, James Coombs, Stockton Press. As stated there, "traditionally, buffers based on inorganic salts (phosphate, carbonate) and organic acid salts (acetate, citrate, succinate, glycine, maleate, barbiturates, etc.) were used in biological experiments."
It is the object of this invention to discover buffers and electrolytes which are advantageously used in molecular biology electronic devices which perform hybridizations, reactions, diagnostics or synthesis.
Summary of the Invention
The following inventions relate to our discoveries concerning the various parameters, electrolytes (buffers) , and other conditions which improve or optimize the speed of DNA transport, the efficiency of DNA hybridization reactions, and the overall hybridization specificity in our APEX microelectronic chips and devices. In particular, this invention relates to the discovery that low conductance zwitterionic buffer solutions, especially those containing the amino acid Histidine prepared at concentrations of 10-100 mM, preferably about 50 mM, and at or near the pi (isoelectric point -pH 7.47), provide optimal conditions for both rapid DNA transport and efficient hybridization reactions. Hybridization efficiencies of at least a factor of 10 relative to the next best known buffer, Cysteine, are achieved. Test data demonstrate an approximately 50,000 fold increase in hybridization efficiency compared to Cysteine.
Brief Description of the Drawings
Fig. 1 is a plan view of a checkerboard arrangement utilizing a histidine buffer.
Detailed Description of the Invention
There are various physical parameters which relate to the electrophoretic transport of DNA and other charged analytes in various types of electrolyte/buffer solutions. Certain of the devices, e.g., Applicant's APEX device as described in United States Patent No. 5,605,662, referenced above, are basically DC (direct current) electrical devices which generate electric fields on the surface of the device. These fields, in turn, cause the
electrophoretic transport of charged molecules to occur between oppositely (+/-) biased microlocations on the device surface. By contrast the so-called Genosensor (impedance sensors), see, e.g., Hollis et al, "Optical and Electrical Methods and Apparatus for Molecular Detection", 093/22678, and dielectrophoresis devices, see, e.g., Washizu 25 Journal of Electrostatics, 109-123, 1990, involve the use of AC electric fields. An important distinction related to these devices is that when these AC fields are applied, there is essentially no net current flow in any of these systems, i.e, there is no electrophoretic propulsion for transport of the charged molecules. APEX type devices produce significant net direct current (DC) flow when a voltage is applied, which is recognized as "the signature of electrophoresis" . In electrophore- sis, the migration of ions or charged particles is produced by electrical forces along the direction of the electric field gradient, and the relationship of current and voltage are important to this technology. The electrophoretic migration shows itself macroscopically as the conduction of electric current in a solution under the influence of an applied voltage and follows Ohm's law: V=RxI V is the electric potential R is the electric resistance of the electrolyte [VxA~ 1=R(Ω)]
I is the electric current [A] .
The resistance of the solution is the reciprocal of the conductance which can be measured by a conductomete . The conductance depends mainly on the ionic species of the buffer/electrolytes and their concentration; therefore these parameters are very important for electric field related molecular biology technology. The basic current/voltage relationships are essentially the same for the APEX technology as for any other electrophoretic system, although the electric fields produced are in truly microscopic environments.
There are unique features of the APEX system regarding the various ways of sourcing the current and voltage, and how the current and voltage scenarios have been found to improve the performance of such systems . In particular, various DC pulsing procedures (linear and logarithmic gradients) appear to provide improved hybridization stringency.
Electrophoretic Transport Versus Ionic Strength
It is well established in the field of electro- phoresis that there is a logarithmic decrease in the mobility of the charged analyte species (proteins, DNA, etc.), which is inversely proportional to the square root of the ionic strength of the electrolyte solution (see page 83 and Fig. 3.16 in "Capillary Electrophoresis : Principles and Practice", R. Kuhn and S. Hoffstetter, Springer-Verlag, 1993) . At any given constant electric field strength, as the electrolyte concentration decreases relative to the analyte species (protein, DNA, etc.), the analyte will be transported at a faster rate. Similar results demonstrating this effect for a danyslated amino acid have been shown by J.J. Issaq et . al., Chromatographia Vol. 32, #3/4, August 1991, pages 155 to 161 (see in particular Fig. 3 on page 157) . Results demonstrating this effect for DNA is different electrolyte solutions has been shown in P.D. Ross and R.L. Scruggs, Biopolymers Vol. 2, pages 231 to 236, 1964 (see in particular Fig. 1, page 232) .
Ionic Strength/Conductance Relationship
For those non-buffering electrolytes (sodium chloride, potassium chloride, etc.) which involve completely dissociated anion and cation species in solution (Na+ < > Cl", K* < > Cl", etc.), the ionic strength and conductance are equivalent, i.e., the conductance will usually be proportional to the ionic strength. For those buffering electrolytes (phospr e,
acetate, citrate, succinate, etc.) which are in their dissociated states (example: 2 Na+ < > P04 ""2) , the ionic strength and conductance will usually be equivalent, i.e., conductance is proportional to the ionic strength. For those buffering electrolytes [Good Buffers (MOPS, HEPES, TAPS, Tricine, Bicine) , Amino Acid Buffers, Ampholytes, etc.] which can have a zwitterionic species (no net charge at their pi) , the conductance will decrease by approximately a factor of 10 for every pH unit difference between the isoelectric point (pi) and the (pKa) . For example, an amino acid in its zwitterionic state ("OOC-CH(R) -NH3*) will have a conductance value which will be approximately 1000 fold lower than when the " amino acid moiety" has a full net positive charge (HOOC-CH(R) -NH2 * < > x") or a full negative charge (Y+ < >" OOC-CH (R) -NH2) . Thus, a formal negative or positive charge develops on the amino acid moiety as it moves away from its pi, and the conductivity and ionic strength will begin to correlate. However, when at or near the pi the conductance will be much lower than is expected for that given ionic strength or concentration. When used at or near their pi's, electrophoresis texts refer to the Good Buffers and amino acid buffers as having "low conductances at high ionic strength or concentration" (see page 88 of Capillary Electrophoresis: Principles and Practice", R. Kuhn and S. Hoffstetter, Springer - Verlag, 1993) . A commonly used electrophoresis buffer "Tris-Borate" actually has a significantly lower conductivity than would be expected from its ionic strength or concentration. This may be due to the "tris cation" and "borate anion" forming a relatively stable zwitterionic complex in solution. The conductivity of a 100 mM Tris-Borate solution was determined to be 694 μS/cm, which is approximately 20 times lower than would be expected from its ionic strength, and is roughly equiva- lent to a 5 mM sodium phosphate or sodium chloride solution. Table 1 shows conductivity measurements of a number of transport buffers.
Table 1
Zwitterionic Buffers/Conductance/Transport Rate
Certain advantages exist regarding the rate or speed of electrophoretic transport of DNA when using Zwitterionic buffers (Good buffers, amino acid buffers) , or the Tris-Borate buffer at or near their pis. These are: 1) such buffers can be used at relatively high concentrations to increase buffering capacity, 2) their conductances are significantly lower than other types of buffers at the same concentration, and 3) one gains the advantage of higher electrophoretic transport rates for the analyte of interest (DNA) .
Zwitterionic Buffer Capacity at the Isoelectric Point (pi)
Amino acid buffers do have buffer properties at their pi's. While a given amino acid may or may not have its "highest buffering capacity" at its pi, it will have some degree of buffering capacity. Buffer capacity decreases by a factor of 10 for every pH unit difference between the pi and the pKa; those amino acids with three ionizable groups (histidine, cysteine, lysine, glutamic acid, aspartic acid, etc.) generally have higher buffering capacities at their pi's than those amino acids with only two dissociations (glycine, alanine, leucine, etc.). For example, histidine pi = 7.47, lysine pl=9.74, and glutamic acid pl=3.22, all have relatively good buffering capacity at their pis, relative to alanine or glycine which have relatively low buffering capacities at their pis (see A.L. Lehninger, Biochemistry, 2ed, Worth Publishers, New York, 1975; in particular Fig. 4-8 on page 79, and Fig. 4-9 on page 80) . Histidine has been proposed as a buffer for use in gel electrophoresis, see, e.g., U.S. Patent 4,936,963, but hybridization is not performed in such systems. Cysteine is in a more intermediate position, with regard to buffering capacity. The pi of cysteine is 5.02, the pKa for the carboxyl group is 1.71, the pKa for the sulfhydryl is 8.33, and the pKa for amino group is 10.78. An acid /base titration curve of 250 mM cysteine,
shows that cysteine has a better "buffering capacity" at ~ pH 5 than a 20 mM sodium phosphate. In the pH 4 to 6 range, the buffering capacity of cysteine is significantly better than 20 mM sodium phosphate, particularly at the higher pH. However, in these pH ranges the conductance of the 250 mM cysteine solution is very low -23 μS/cm, compared to 20 mM sodium phosphate which has a value of -2.9 mS/cm, a factor of 100 times greater. Figure 1 shows the Conductivity Measurements of Various Transport Buffers.
Several electrophoretic techniques developed over 20 years ago are based on the ability to separate proteins in zwitterionic buffers "at their pis." These techniques are called Isoelectrophoresis, Isotachophoresis, and Electrofocusing (see chapters 3 and 4 in "Gel Electrophoresis of Proteins: A Practical Approach" Edited by B.D. Hames & D. Rickwood, IRL Press 1981). Various amino acid buffers and Good buffers were used for these applications, all at their pi's (see Table 2, page 168 of the above reference) .
DNA Transport in Low Ionic Strength and Low Conductance Buffers
A series of fluorescent checkerboard experiments were carried out using 2.5% agarose coated 5580 chips and the ByTr-RCA5 fluorescent probe. We were able to achieve rapid (6 second) checkerboard addressing in all of the following systems: (1) 250 mM HEPES (low conductance), (2) 10 μM sodium succinate, (3) 10 μM sodium citrate, and (4) distilled water. The results for sodium citrate are shown in Figure 1. While, some types of low conductance or low ionic strength solutions may have somewhat better characteristics, checkerboard addressing and rapid DNA transport (6 to 12 second DNA accumulation on an 80 μm pad) were achieved using all of these systems. Additionally, DNA addressing APEX chips in distilled water is possible because the DNA (itself a polyanion) is the
electrolyte present in the bulk solution which provides the conductance. Fig. 1 shows a plan view of an APEX chip using histidine.
Relationship of Electrophoretic Transport Rate and the Cation/Anion Species
In addition to the fact that the mobility of the charged analyte species (DNA, proteins, etc.) is related to the ionic strength of the electrolyte solution, the mobility is also greatly influenced by the nature of the cation and anion species in the electrolyte solution (see pp 89 of "Capillary Electrophoresis: Principles and Practice" reference) . This particular point is demonstrated for DNA transport in the above Biopolymers, Vol. 2, pp. 231-236, 1964 reference. Figure 1 on page 232 of this reference shows the change in DNA mobility when using electrolytes with different univalent anions (Li + > Na + > K + > TMA *) at the same ionic strength. Basically, different cations can have different association constants with the DNA phosphate groups, and/or change the hydration spheres around the DNA molecules, which leads to a change in their transport rate.
The instant invention relates to our discoveries concerning the various parameters, electrolytes (buffers) , and other, conditions which improve or optimize the speed of DNA transport, the efficiency of DNA hybridization reactions, and the overall hybridization specificity in electric field molecular biology devices, especially APEX microelectronic chips and devices. In particular, this invention relates to our discovery that low conductance zwitterionic buffer solutions containing the amino acid Histidine prepared at concentrations of 10-100 mM, especially about 50 mM, at or near the pi (isoelectric point -7.47), provide optimal conditions for both rapid electrophoretic DNA transport and efficient hybridization reactions. This advantage of the Histidine buffer is particularly important for the APEX chip type devices .
These particular devices (as opposed to the micromachined type devices) have limitations as to the amount of current and voltages that can be applied. This limitation makes it difficult to achieve both rapid transport and efficient hybridization using the same buffer system. In these cases, DNA transport was carried out in a low conductance buffer (Cysteine or Alanine) where the limited current/voltage still produced rapid transport. Under these conditions the DNA accumulated at the test site, but did not hybridize as efficiently. After transport in these low conductance buffers, the solution was changed to a high salt buffer (> 100 mM sodium chloride or sodium phosphate) which then produced an efficient hybridization at the test site. Table 2 shows the results for a series of experiments which correlate the parameters of buffer capacity, pH, and the conductivity, with DNA accumulation and hybridization sensitivity (efficiency) using the APEX chip device.
TABLE 2
In particular, Table 2 shows the effect of various zwitterionic amino acid buffers [jβ-Alanine, Taurine, Cysteine, Histidine, Lysine, and Sodium Phosphate (not a zwitterionic buffer) ] on the hybridizability of the transported target DNA to the specific capture DNA at the test site. As to transport, the conductivity generally correlates with transport under the same field conditions. /3-Alanine, Taurine and Cysteine show excellent transport, Histidine shows good transport, and Lysine and NaP04 show fair transport. The DNA hybridization sensitivity is reported for "normal DNA" which has negatively charged polyanionic phosphate backbone. In addition to the hybridization sensitivities, Table 2 also reports the sensitivity for the streptavidin/biotin DNA probe capture affinity.
Table 2 clearly shows the correlation of DNA transport (accumulation) with low conductivity (jβ-Alanine, Taurine, Cysteine, Histidine) . The table shows good
20mM NaP04 adjusted to pH 7 .4
sensitivity for the streptavidin/biotin probe affinity reaction using /3-Alanine, Cysteine, and Histidine. As reflected in the sensitivity data in Table 2, Histidine provides over four orders of magnitude better hybridization efficiency then either Cysteine or other buffers, such as 20 mM NaP04. The improvement relative to Cysteine is at least a factor of 10, more especially a factor of 102, and most especially at least a factor of 104. Most importantly Table 2 shows that the DNA hybridization sensitivity (efficiency) is very good for the Histidine buffer. Thus of all the zwitterionic amino acid buffers presently tested, Histidine is the only one which provides both good transport and good DNA/DNA hybridization efficiency. It is believed that the low conductivity of the Histidine buffer system accounts for the rapid DNA transport (accumulation) . There are several possible explanations as to why the Histidine buffer produces relatively efficient DNA/DNA hybridization. One advantage may be the good buffering capacity of Histidine. With its pi at 7.47, Histidine will buffer well under both acidic or basic conditions (see A.L. Lehninger, Biochemistry, 2ed, Worth Publishers, New York, 1975, Fig. 4-9 on page 80) . The APEX chip produces acid at the positive electrode where the DNA is accumulated for hybridization, and Histidine may effectively buffer these conditions. More importantly, under these acidic conditions (pH<5) the protonation of the imidazole group on the Histidine begins to convert the molecule into a dicationic species. It may be the case that this dicationic species with a positively charged a-amino group and a positively charge imidazole group may help to promote hybridization and stabilize the DNA/DNA hybrids formed at the positive electrode on the APEX chip. Cations, dications, and polycations are known to help stabilize DNA/DNA hybrids by reducing the repulsion of the negatively charged phosphate backbones on the double-stranded DNA structure. It is also possible
that the DNA/DNA/Histidine may also form some type of stabilizing adduct from other electrochemical products being produced at the positive electrode (hydrogen peroxide, etc.) While the instant embodiment utilizes naturally occurring Histidine, this invention is fully applicable to other natural or synthetic compounds which have good buffering capacity, low conductivity (or zwitterionic characteristics) and have properties which allow DNA hybridization to be stabilized by charge stabilization or adduct formation.
Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity and understanding, it will be readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto without departing from the spirit or scope of the appended claims.
Claims
Claims
1. A method for transporting and hybridizating target nucleic acids in a microelectronic device having at least one test site bearing a capture nucleic acid, comprising the steps of:
(1) applying a low conductance buffer to the device,
(2) applying current to the device to produce an electric field at the test site, (3) transporting the target nucleic acids to the test site, and (4) hybridizing the target nucleic acids to the capture nucleic acid at the test site with a hybridization efficiency which is at least a factor of 10 times greater than for
Cysteine under the same conditions.
2. The method of claim 1 wherein the low conductivity buffer is a zwitterionic buffer.
3. The method of claim 2 wherein the zwitterionic buffer includes histidine.
4. The method of claim 3 wherein the histidine was prepared at a concentration of about 10-100 mM.
5. The method of claim 3 wherein the histidine was prepared at or about the isoelectric point .
6. The method of claim 1 wherein the isoelectric point is about pH 7.47.
7. The method of claim 1 wherein the buffer entity stabilizes hybridization between the target nucleic acids and the capture nucleic acid.
8. The method of claim 7 wherein the buffer entity is a natural compound with low conductivity.
9. The method of claim 7 wherein the buffer entity is a natural, zwitterionic compound.
10. The method of claim 7 wherein the buffer entity is a synthetic compound with low conductivity.
11. The method of claim 7 wherein the buffer entity is a synthetic, zwitterionic compound.
12. The method of claim 1 wherein the hybridization efficiency is at least a factor of 100 times greater than for Cysteine under the same conditions.
13. The method of claim 1 wherein the hybridization efficiency is at least a factor of 1,000 times greater than for Cysteine under the same conditions.
14. The method of claim 1 wherein the hybridization efficiency is at least a factor of approximately 50,000 times greater than for Cysteine under the same conditions.
15. The method of claim 1 wherein the buffer entity reduces repulsion between the capture nucleic acid and the target nucleic acids.
16. The method of claim 1 wherein the buffer reduces adduct formation between the capture nucleic acid and the target nucleic acids.
17. A method for enhancing the electrophoretic transport and hybridization efficiency of target nucleic acids in a microelectronic hybridization device including a microlocation test site having a capture nucleic acid, comprising the steps of :
applying a low conductivity buffer to the device, applying power to the device to cause electrophoretic transport and accumulation of the target nucleic acids at a microlocation test site on the device, and hybridizing the target nucleic acids with an efficiency which is at least a factor of 10 times greater than for Cysteine under the same conditions.
18. The method of claim 17 wherein the low conductivity buffer is a zwitterionic buffer.
19. The method of claim 18 wherein the zwitterionic buffer includes histidine.
20. The method of claim 19 wherein the histidine was prepared at a concentration of about 10-100 mM.
21. The method of claim 19 wherein the histidine was prepared at or about the isoelectric point.
22. The method of claim 17 wherein the isoelectric point is about pH 7.47.
23. The method of claim 17 wherein the buffer entity stabilizes hybridization between the target nucleic acids and the capture nucleic acid.
24. The method of claim 23 wherein the buffer entity is a natural compound with low conductivity.
25. The method of claim 23 wherein the buffer entity is a natural, zwitterionic compound.
26. The method of claim 23 wherein the buffer entity is a synthetic compound with low conductivity.
27. The method of claim 23 the buffer entity is a synthetic, zwitterionic compound.
28. The method of claim 17 wherein the hybridization efficiency is at least a factor of 100 times greater than for Cysteine under the same conditions.
29. The method of claim 17 wherein the hybridization efficiency is at least a factor of 1,000 times greater than for Cysteine under the same conditions.
30. The method of claim 17 wherein the hybridization efficiency is at least a factor of approximately 50,000 times greater than for Cysteine under the same conditions.
31. The method of claim 17 wherein the buffer entity reduces repulsion between the capture nucleic acid and the target nucleic acids.
32. The method of claim 17 wherein the buffer reduces adduct formation between the capture nucleic acid and the target nucleic acids.--
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70826296A | 1996-09-06 | 1996-09-06 | |
| US708262 | 1996-09-06 | ||
| PCT/US1997/014489 WO1998010273A1 (en) | 1996-09-06 | 1997-08-18 | Methods and materials for optimization of electronic hybridization reactions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1019711A1 EP1019711A1 (en) | 2000-07-19 |
| EP1019711A4 true EP1019711A4 (en) | 2001-06-13 |
Family
ID=24845074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP97938378A Withdrawn EP1019711A4 (en) | 1996-09-06 | 1997-08-18 | Methods and materials for optimization of electronic hybridization reactions |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1019711A4 (en) |
| JP (1) | JP4213216B2 (en) |
| KR (1) | KR100591626B1 (en) |
| CN (1) | CN1180248C (en) |
| AU (1) | AU723564B2 (en) |
| BR (1) | BR9712800A (en) |
| CA (1) | CA2264780C (en) |
| NZ (1) | NZ334314A (en) |
| WO (1) | WO1998010273A1 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6051380A (en) * | 1993-11-01 | 2000-04-18 | Nanogen, Inc. | Methods and procedures for molecular biological analysis and diagnostics |
| US6468742B2 (en) | 1993-11-01 | 2002-10-22 | Nanogen, Inc. | Methods for determination of single nucleic acid polymorphisms using bioelectronic microchip |
| US6379897B1 (en) * | 2000-11-09 | 2002-04-30 | Nanogen, Inc. | Methods for gene expression monitoring on electronic microarrays |
| US5964995A (en) * | 1997-04-04 | 1999-10-12 | Caliper Technologies Corp. | Methods and systems for enhanced fluid transport |
| US6238909B1 (en) * | 1999-05-04 | 2001-05-29 | Motorola, Inc. | Method and apparatus for obtaining electric field-enhanced bioconjugation |
| CA2361679A1 (en) * | 1999-09-27 | 2001-04-05 | Dutt V. Vinjamoori | Methods for determining oils in seeds |
| US7309581B2 (en) * | 2000-11-01 | 2007-12-18 | Sysmex Corporation | Method of staining, detection and counting bacteria, and a diluent for bacterial stain |
| GB0205455D0 (en) | 2002-03-07 | 2002-04-24 | Molecular Sensing Plc | Nucleic acid probes, their synthesis and use |
| US7153687B2 (en) | 2002-08-13 | 2006-12-26 | Hong Kong Dna Chips Limited | Apparatus and methods for detecting DNA in biological samples |
| JP4464664B2 (en) * | 2003-06-13 | 2010-05-19 | 独立行政法人理化学研究所 | Biomolecule microarray substrate, biomolecule microarray, device and method for promoting interaction, and method for detecting interaction |
| US7314542B2 (en) * | 2004-09-23 | 2008-01-01 | Nanogen, Inc. | Methods and materials for optimization of electronic transportation and hybridization reactions |
| KR100785011B1 (en) * | 2006-04-07 | 2007-12-11 | 삼성전자주식회사 | Method for increasing the specificity of nucleic acid hybridization using zwitterionic compounds |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996001836A1 (en) * | 1994-07-07 | 1996-01-25 | Nanogen, Inc. | Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics |
| WO1996015576A1 (en) * | 1994-11-10 | 1996-05-23 | David Sarnoff Research Center, Inc. | Liquid distribution system |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4936963A (en) * | 1987-05-27 | 1990-06-26 | Abbott Laboratories | Polycationic buffers and method for gel electrophoresis of nucleic acids |
| US5188963A (en) * | 1989-11-17 | 1993-02-23 | Gene Tec Corporation | Device for processing biological specimens for analysis of nucleic acids |
| US5585069A (en) * | 1994-11-10 | 1996-12-17 | David Sarnoff Research Center, Inc. | Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis |
-
1997
- 1997-08-18 WO PCT/US1997/014489 patent/WO1998010273A1/en active IP Right Grant
- 1997-08-18 CN CNB97197960XA patent/CN1180248C/en not_active Expired - Fee Related
- 1997-08-18 BR BR9712800-7A patent/BR9712800A/en unknown
- 1997-08-18 KR KR1019997001868A patent/KR100591626B1/en not_active IP Right Cessation
- 1997-08-18 CA CA002264780A patent/CA2264780C/en not_active Expired - Fee Related
- 1997-08-18 EP EP97938378A patent/EP1019711A4/en not_active Withdrawn
- 1997-08-18 JP JP51267698A patent/JP4213216B2/en not_active Expired - Lifetime
- 1997-08-18 NZ NZ334314A patent/NZ334314A/en unknown
- 1997-08-18 AU AU40719/97A patent/AU723564B2/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996001836A1 (en) * | 1994-07-07 | 1996-01-25 | Nanogen, Inc. | Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics |
| WO1996015576A1 (en) * | 1994-11-10 | 1996-05-23 | David Sarnoff Research Center, Inc. | Liquid distribution system |
Non-Patent Citations (2)
| Title |
|---|
| EDMAN C ET AL: "Electric field directed nucleic acid hybridization on microchips", NUCLEIC ACIDS RESEARCH, vol. 25, no. 24, 1997, pages 4907 - 14, XP002165640 * |
| See also references of WO9810273A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1019711A1 (en) | 2000-07-19 |
| CA2264780C (en) | 2006-08-01 |
| JP4213216B2 (en) | 2009-01-21 |
| KR100591626B1 (en) | 2006-06-20 |
| WO1998010273A1 (en) | 1998-03-12 |
| CN1180248C (en) | 2004-12-15 |
| KR20010029477A (en) | 2001-04-06 |
| AU4071997A (en) | 1998-03-26 |
| CN1230255A (en) | 1999-09-29 |
| AU723564B2 (en) | 2000-08-31 |
| CA2264780A1 (en) | 1998-03-12 |
| BR9712800A (en) | 1999-11-23 |
| NZ334314A (en) | 2000-09-29 |
| JP2001501301A (en) | 2001-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4787963A (en) | Method and means for annealing complementary nucleic acid molecules at an accelerated rate | |
| US8241476B1 (en) | Sol-gel coatings for on-line preconcentration in capillary electrophoresis | |
| AU723564B2 (en) | Methods and materials for optimization of electronic hybridization reactions | |
| WO1998010273A9 (en) | Methods and materials for optimization of electronic hybridization reactions | |
| US20080314751A1 (en) | Electrophoretic Separation of Analytes by Molecular Mass | |
| Righetti et al. | Current trends in capillary isoelectric focusing of proteins | |
| Iborra et al. | Protein subunit mapping. A sensitive high resolution method | |
| Wang et al. | On-line concentration of trace proteins by pH junctions in capillary electrophoresis with UV absorption detection | |
| Kartsova et al. | Preconcentration techniques in capillary electrophoresis | |
| Cifuentes et al. | Separation of basic proteins by capillary electrophoresis using cross-linked polyacrylamide-coated capillaries and cationic buffer additives | |
| US20130008795A1 (en) | Electrophoresis apparatus | |
| US7314542B2 (en) | Methods and materials for optimization of electronic transportation and hybridization reactions | |
| US20140114053A1 (en) | Electrophoresis Separation Methods | |
| Chun et al. | Protein analysis with large volume sample stacking with an electrosmotic flow pump: a potential approach for proteomics | |
| Li et al. | Negatively charged sol‐gel column with stable electroosmotic flow for online preconcentration of zwitterionic biomolecules in capillary electromigration separations | |
| JPH10500489A (en) | Method for desalting biological samples to remove interfering substances in isoelectric focusing | |
| US20100032296A1 (en) | Systems and methods for quantitative analyte transfer | |
| Smejkal et al. | Solution phase isoelectric fractionation in the multi-compartment electrolyser: A divide and conquer strategy for the analysis of complex proteomes | |
| Doble et al. | Factors influencing the choice of buffer in background electrolytes for indirect detection of fast anions by capillary electrophoresis | |
| JPH05508931A (en) | Improvement of gel-in-gel composition for in-liquid gel electrophoresis | |
| JP2003114216A (en) | Electrophoretic device | |
| Garfin | Electrophoretic methods | |
| Rajput et al. | Western Blot: Theoretical Aspects | |
| CN107488208B (en) | Isoelectric focusing and separation method of carrier-free ampholyte | |
| Cooper et al. | Electronic gel protein transfer and identification using matrix‐assisted laser desorption/ionization‐mass spectrometry |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19990401 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20010504 |
|
| AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| 17Q | First examination report despatched |
Effective date: 20061123 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20081021 |